Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1

Nature Genetics

Volumn 19, Issue 2, 1998, Pages 162-166

  Timpl, Peter ^a   Spanagel, Rainer ^a   Sillaber, Inge ^a   Kresse, Adelheid ^a   Reul, Johannes M H M ^a   Stalla, Günter K ^a   Blanquet, Veronique ^a,b   Steckler, Thomas ^a   Holsboer, Florian ^a   Wurst, Wolfgang ^a,b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR;

ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CORTICOSTERONE RELEASE; CORTICOTROPIN RELEASE; ENZYME ACTIVATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; STRESS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANXIETY; CELLS, CULTURED; CORTICOSTERONE; ETHANOL; IN SITU HYBRIDIZATION; MICE; MICE, KNOCKOUT; PITUITARY GLAND; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 17344362093     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/520     Document Type: Article

References (30)

1. Menzaghi, F. et al. The role of corticotropin-releesing factor in the anxiogenic effects of ethanol withdrawal. Ann. N. Y. Acad. Sci. 739, 175-184 (1994).
2. Pich, E.M. et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 15, 5439-5447 (1995).
3. Vita, N. et al. Primary structure and functional expression of mouse pituitary and human brain corticotrophin releasing factor receptors. FEBS Lett. 335, 1-5 (1993).
4. Kishimoto, T, Pearse, R.V., Lin C.R. & Rosenfeld, M.G. A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle. Proc. Natl. Acad. Sci. USA 92, 1108-1112 (1995).
5. 1 receptor mRNA expression. J. Neurosci. 15, 6340-6350 (1995).
6. De Souza, E.B. Corticotropin-releasing factor receptors: physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinol. 20, 789-819 (1995).
7. Aguilera, G., Abou-Samra, A.B., Harwood, J.P. & Catt, K.J. Corticotropin releasing factor receptors: characterization and actions in the anterior pituitary gland. Adv. Exp. Med. Biol. 245, 83-106 (1988).
8. Bilezikjian L.M. & Vale, W.W. Glucocorticoids inhibit corticotropin-releesing factor-induced production of adenosine 3′,5′-monophosphate in cultured anterior pituitary cells. Endocrinol. 113, 657-662 (1983).
9. Vale, W., Spiess, J., Rivier, C. & Rivier, J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213, 1394-1397 (1981).
10. Holsboer, F., Spengler, D. & Heuser, I. The role of corticotropin-releasing hormone in the pathogenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. Prog. Brain Res. 93, 385-416 (1992).
11. Owens, M.J. & Nemeroff. C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol. Rev. 43, 425-473 (1991).
12. Swanson, L.W. & Simmons, D.M. Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat. J. Comp. Neurol. 285, 413-435 (1989).
13. Cole, T.J. et al. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9, 1608-1621 (1995).
14. Edwards, A.V. & Jones, C.T. The effect of splanchnic nerve section on the sensitivity of the adrenal cortex to adrenocorticotrophin in the calf. J. Physiol. 390, 23-31 (1987).
15. Bornstein, S.R., Ehrhart-Bornstein, M., Scherbaum, W.A. Pfeiffer, E.F. & Holst, J.J. Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinol. 127, 900-906 (1990).
16. Stenzel-Poore, M.P., Heinrichs, S.C., Rivest, S., Koob, G.F. & Vale, W.W. Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J. Neurosci. 14, 2579-2584 (1994).
17. 9-41. Pharmacol. Biochem. Behav. 48, 497-503 (1994).
18. Moreau, J.L., Kilpatrick, G. & Jenck, F. Urocortin, a novel neuropeptide with anxiogenic-like properties. Neuroreport 8, 1697-1701 (1997).
19. Liebsch, G. et al. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul. Pept. 59, 229-239 (1995).
20. Koob, G.F. Drug addiction: the yin and yang of hedonic homeostasis. Neuron 16, 893-896 (1996).
21. Rassnick, S., Heinrichs, S.C., Britton, K.T. & Koob, G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 605, 25-32 (1993).
22. Tabakoff, B., & Hoffmann, P. L. Alcohol addiction: An enigma among us. Neuron 16, 909-912 (1996).
23. Evans, G.A., Lewis, K. & Rothenberg, B.E. High efficiency vectors for cosmid microcloning and genomic analysis. Gene 79, 9-20 (1989).
24. Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T & Mulligan, R.C. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-ab1 proto-oncogene. Cell 65, 1153-1163 (1991).
25. Wurst, W. & Joyner, A.L. Production of targeted embryonic stem cell clones, in Gene Targeting, A Practical Approach (ed. Joyner, A.L.) 33-61 (IRL Press, Oxford, 1993).
26. Stalla, G.K. et al. Ketoconazole inhibts corticotropic cell function in vitro. Endocrinol. 122, 618-623 (1988).
27. Karanth, S. et al. Hypothalamic-pituitary-adrenocortical axis changes in a transgenic mouse with impaired glucocorticoid receptor function. Endocrinol. 138, 3476-3485 (1997).
28. Kresse, A., Jacobowitz, D.M. & Skofitsch, G. Detailed mapping of CGRP mRNA expression in the rat central nervous system: Comparison with previous immunocytochemical findings. Brain Res. Bull. 36, 261-274 (1995).
29. Spanagel, R., Putzke, J., Stefferl, A., Schöbitz, B. & Zieglgängsberger, W. Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur. J. Pharmacol. 305, 45-50 (1996).
30. Crabbe, J.C. et al. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nature Genet. 14, 98-101 (1996).